Published :
Tables : 19
Figures : 31
Category : Healthcare
No. of Pages : 225
Report Code : HC-1046
Radiation Dose Management Market Introduction: The Global Radiation Dose Management Market is estimated to value over USD 480 million by 2027 end with a CAGR of over 13.3% during the forecast period 2020 to 2027. Radiation dose is defined as radiation effect on the skin; it depends on the intensity of radiation, exposure time and sensitivity of the skin. The management of radiation dose components includes information of radiation dose recording software, real-time staff dose monitoring, regulatory compliance and technologies to reduce the dose. There are various techniques like scintigraphies which can deliver low dose radiation with high-quality images of diagnosis, which can calculate and record the dose level and helps in the managing the patient data and sharing with regulatory authorities. Nowadays more patients are investigated through radiation technology to deliver accurate information on disease/disorder. The growing importance of imaging techniques in the preliminary diagnosis of chronic diseases led to the increasing demand for radiation dose management. Rising demand is further augmented by increasing safety concerns of radiation fuelled the growth of the global radiation dose management market. Further, the rising complexity of imaging techniques led to the development of specific guidelines for better management of radiation dose in primary healthcare settings. Additionally, changing healthcare environment and regulatory scenarios to minimize the radiation complications have boosted the growth of the market. In the recent past, radiation dose management is becoming an integral part of healthcare systems to minimize radiation exposure. The market is expected to witness double growth rate during the forecast period due to increasing adoption radiation dose management techniques in healthcare systems. North America and Europe radiation dose management markets account major share in the global market due to high penetration among the end-user segments. European radiation dose management market is expected to witness new market players due to rising capital investments among end-user segment. Rising economic conditions in Asia Pacific region is expected to create a potential opportunity space for the market. Latin America and Rest of the world market are expected to witness significant growth rate during the forecast period. Radiation Dose Management market players include: Siemens Healthineers, Philips Healthcare, Ge Healthcare, Qaelum N.V., Fujifilm Holdings Corporation ,Bayer Ag, Sectra Ab, Agfa Healthcare, Canon, Inc., Guerbet, Pacshealth, Llc, Novarad Corporation, Bracco Imaging S.P.A, Infinitt Healthcare, Medsquare Sas, Volpara Solutions Limited, Medic Vision. Radiation Dose Management Market Segmentation : By Product and Services Radiation Dose Management Solutions Standalone Solutions Integrated Solutions Radiation Dose Management Services Support & Maintenance Services Implementation & Integration Services Consulting Services Education & Training Services By Modality Computed Tomography Fluoroscopy & Interventional Imaging Radiography & Mammography Nuclear Medicine By Application Oncology Cardiology Orthopedic Applications Others By End User Hospitals Small Hospitals Large Hospitals Ambulatory Care Settings Others By Region Europe North America APAC Latin America Rest of World Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on global radiation dose management market by product and services, by modality, by application, by end user and region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Radiation dose is defined as radiation effect on the skin; it depends on the intensity of radiation, exposure time and sensitivity of the skin. The management of radiation dose components includes information of radiation dose recording software, real-time staff dose monitoring, regulatory compliance and technologies to reduce the dose. There are various techniques like scintigraphies which can deliver low dose radiation with high-quality images of diagnosis, which can calculate and record the dose level and helps in the managing the patient data and sharing with regulatory authorities. Nowadays more patients are investigated through radiation technology to deliver accurate information on disease/disorder.
The growing importance of imaging techniques in the preliminary diagnosis of chronic diseases led to the increasing demand for radiation dose management. Rising demand is further augmented by increasing safety concerns of radiation fuelled the growth of the global radiation dose management market. Further, the rising complexity of imaging techniques led to the development of specific guidelines for better management of radiation dose in primary healthcare settings. Additionally, changing healthcare environment and regulatory scenarios to minimize the radiation complications have boosted the growth of the market. In the recent past, radiation dose management is becoming an integral part of healthcare systems to minimize radiation exposure. The market is expected to witness double growth rate during the forecast period due to increasing adoption radiation dose management techniques in healthcare systems.
North America and Europe radiation dose management markets account major share in the global market due to high penetration among the end-user segments. European radiation dose management market is expected to witness new market players due to rising capital investments among end-user segment. Rising economic conditions in Asia Pacific region is expected to create a potential opportunity space for the market. Latin America and Rest of the world market are expected to witness significant growth rate during the forecast period.
Radiation Dose Management market players include:
Siemens Healthineers, Philips Healthcare, Ge Healthcare, Qaelum N.V., Fujifilm Holdings Corporation ,Bayer Ag, Sectra Ab, Agfa Healthcare, Canon, Inc., Guerbet, Pacshealth, Llc, Novarad Corporation, Bracco Imaging S.P.A, Infinitt Healthcare, Medsquare Sas, Volpara Solutions Limited, Medic Vision.
Radiation Dose Management Market Segmentation :
By Product and Services
By Modality
By Application
By End User
By Region
Competitive Landscape:
FutureWise Takeaways:
Objectives of the Study:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Radiation Dose Management Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Radiation Dose Management Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Radiation Dose Management Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Radiation Dose Management Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Radiation Dose Management Market, By Product and Services Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Radiation Dose Management Solutions 7.1.1. Standalone Solutions 7.1.2. Integrated Solutions 7.2. Radiation Dose Management Services 7.2.1.Support & Maintenance Services 7.2.2. Implementation & Integration Services 7.2.3. Consulting Services 7.2.4. Education & Training Services 8. Global Radiation Dose Management Market, By Modality Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Computed Tomography 8.2. Fluoroscopy & Interventional Imaging 8.3. Radiography & Mammography 8.4. Nuclear Medicine 9. Global Radiation Dose Management Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Oncology 9.2. Cardiology 9.3. Orthopedic Applications 9.4. Others 10. Global Radiation Dose Management Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Hospitals 10.2. Small Hospitals 10.3. Large Hospitals 10.4. Ambulatory Care Settings 10.5. Others 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 16.1. Siemens Healthineers 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Philips Healthcare 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. GE Healthcare 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. QAELUM N.V. 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Fujifilm Holdings Corporation 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 BAYER AG 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. SECTRA AB 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. AGFA HEALTHCARE 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. CANON, INC. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. GUERBET 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11. PACSHEALTH, LLC 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12. NOVARAD CORPORATION 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13. BRACCO IMAGING S.P.A 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14. INFINITT HEALTHCARE 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15. MEDSQUARE SAS 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16. VOLPARA SOLUTIONS LIMITED 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17. MEDIC VISION 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 17. FutureWise SME Key Takeaway Points for Client
1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Scope
1.3.1. Years Considered for the Study
1.3.2. Market Covered
1.4. Currency
1.5. Limitations
1.6. Stakeholders
2. Research Methodology
2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data
2.1.2.1. Key Data from Primary Sources
2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation
2.4. Assumptions for the Study
3. Executive Summary
3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Radiation Dose Management Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Global Radiation Dose Management Market Overview
5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Radiation Dose Management Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Radiation Dose Management Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Radiation Dose Management Market, By Product and Services Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. Radiation Dose Management Solutions
7.1.1. Standalone Solutions
7.1.2. Integrated Solutions
7.2. Radiation Dose Management Services
7.2.1.Support & Maintenance Services
7.2.2. Implementation & Integration Services
7.2.3. Consulting Services
7.2.4. Education & Training Services
8. Global Radiation Dose Management Market, By Modality Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Computed Tomography
8.2. Fluoroscopy & Interventional Imaging
8.3. Radiography & Mammography
8.4. Nuclear Medicine
9. Global Radiation Dose Management Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. Oncology
9.2. Cardiology
9.3. Orthopedic Applications
9.4. Others
10. Global Radiation Dose Management Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
10.1. Hospitals
10.2. Small Hospitals
10.3. Large Hospitals
10.4. Ambulatory Care Settings
10.5. Others
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.2.1. U.S.A
11.2.2. Canada
11.2.3. Mexico
11.3. Market Size (USD Million) Forecast for North America 2020-2027
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.2.1. Brazil
12.2.2. Venezuela
12.2.3. Argentina
12.2.4. Rest of Latin America
12.3. Market Size (USD Million) Forecast for Latin America 2020-2027
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Germany
13.2.2. U.K
13.2.3. France
13.2.4. Italy
13.2.5. Spain
13.2.6. Russia
13.2.7. Poland
13.2.8. Rest of Europe
13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
14.2.1. Japan
14.2.2. China
14.2.3. India
14.2.4. Australia and New Zealand
14.2.5. ASEAN
14.2.6. Rest of Asia Pacific
14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
15.1. Introduction
15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
15.2.1. Saudi Arabia
15.2.2. UAE
15.2.3. South Africa
15.2.4. Egypt
15.3. Market Size (USD Million) Forecast for MEA 2020-2027
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
16.1. Siemens Healthineers
16.1.1. Company Overview
16.1.2. Product Portfolio
16.1.3. SWOT Analysis
16.1.4. Financial Overview
16.1.5. Strategic Overview
16.2. Philips Healthcare
16.2.1. Company Overview
16.2.2. Product Portfolio
16.2.3. SWOT Analysis
16.2.4. Financial Overview
16.2.5. Strategic Overview
16.3. GE Healthcare
16.3.1. Company Overview
16.3.2. Product Portfolio
16.3.3. SWOT Analysis
16.3.4. Financial Overview
16.3.5. Strategic Overview
16.4. QAELUM N.V.
16.4.1. Company Overview
16.4.2. Product Portfolio
16.4.3. SWOT Analysis
16.4.4. Financial Overview
16.4.5. Strategic Overview
16.5 Fujifilm Holdings Corporation
16.5.1. Company Overview
16.5.2. Product Portfolio
16.5.3. SWOT Analysis
16.5.4. Financial Overview
16.5.5. Strategic Overview
16.6 BAYER AG
16.6.1. Company Overview
16.6.2. Product Portfolio
16.6.3. SWOT Analysis
16.6.4. Financial Overview
16.6.5. Strategic Overview
16.7. SECTRA AB
16.7.1. Company Overview
16.7.2. Product Portfolio
16.7.3. SWOT Analysis
16.7.4. Financial Overview
16.7.5. Strategic Overview
16.8. AGFA HEALTHCARE
16.8.1. Company Overview
16.8.2. Product Portfolio
16.8.3. SWOT Analysis
16.8.4. Financial Overview
16.8.5. Strategic Overview
16.9. CANON, INC.
16.9.1. Company Overview
16.9.2. Product Portfolio
16.9.3. SWOT Analysis
16.9.4. Financial Overview
16.9.5. Strategic Overview
16.10. GUERBET
16.10.1. Company Overview
16.10.2. Product Portfolio
16.10.3. SWOT Analysis
16.10.4. Financial Overview
16.10.5. Strategic Overview
16.11. PACSHEALTH, LLC
16.11.1. Company Overview
16.11.2. Product Portfolio
16.11.3. SWOT Analysis
16.11.4. Financial Overview
16.11.5. Strategic Overview
16.12. NOVARAD CORPORATION
16.12.1. Company Overview
16.12.2. Product Portfolio
16.12.3. SWOT Analysis
16.12.4. Financial Overview
16.12.5. Strategic Overview
16.13. BRACCO IMAGING S.P.A
16.13.1. Company Overview
16.13.2. Product Portfolio
16.13.3. SWOT Analysis
16.13.4. Financial Overview
16.13.5. Strategic Overview
16.14. INFINITT HEALTHCARE
16.14.1. Company Overview
16.14.2. Product Portfolio
16.14.3. SWOT Analysis
16.14.4. Financial Overview
16.14.5. Strategic Overview
16.15. MEDSQUARE SAS
16.15.1. Company Overview
16.15.2. Product Portfolio
16.15.3. SWOT Analysis
16.15.4. Financial Overview
16.15.5. Strategic Overview
16.16. VOLPARA SOLUTIONS LIMITED
16.16.1. Company Overview
16.16.2. Product Portfolio
16.16.3. SWOT Analysis
16.16.4. Financial Overview
16.16.5. Strategic Overview
16.17. MEDIC VISION
16.17.1. Company Overview
16.17.2. Product Portfolio
16.17.3. SWOT Analysis
16.17.4. Financial Overview
16.17.5. Strategic Overview
17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics